Opsens Receives FDA Approval of OptoWire III

 

January 13, 2020—Opsens Inc. announced 510(k) clearance from the FDA to market its OptoWire III coronary pressure guidewire for physiological measurements such as fractional flow reserve (FFR) and diastolic pressure ratio (dPR).

According to the company, the OptoWire family of products is used to diagnose and guide the treatment of patients with coronary heart disease. In addition to the United States and Canada, Opsens has also filed applications for approval in Japan and Europe.

The design of the next-generation OptoWire III device provides increased maneuverability, strength, and a shorter flexible tip, particularly for use in challenging and complex cases. Opsens has also improved the efficiency of the manufacturing process of its flagship product.

Morton Kern, MD, has extensive experience with the OptoWire II device and was the first interventional cardiologist to use OptoWire III in the United States. Dr. Kern is Chief of Medicine at Long Beach VA Medical Center in Long Beach, California.

In Opsens’ announcement, Dr. Kern commented, “I have been using the OptoWire for many years and consider it to be the best pressure guidewire on the market to access, measure, treat, and confirm percutaneous coronary interventions (PCI) in patients with coronary disease. The OptoWire III provides unexpected improvements over the OptoWire II—steerability is on par with workhorse guidewires while providing even more accurate and sustainable measurements.”

Dr. Kern continued, “I also appreciate the ability to measure a variety of indices from FFR to non-hyperemic pressure ratios such as Opsens dPR. I am a firm believer in coronary physiology pre- and post-PCI, and although usage has remained limited mostly due to device limitations. This product is unique and further supports what the clinical studies and medical societies recommend.”

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.